These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 30205701)
1. ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma. Carling U; Røsok B; Line PD; Dorenberg EJ Acta Radiol; 2019 Jun; 60(6):702-709. PubMed ID: 30205701 [TBL] [Abstract][Full Text] [Related]
2. Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma. Hickey R; Mouli S; Kulik L; Desai K; Thornburg B; Ganger D; Baker T; Abecassis M; Ralph Kallini J; Gabr A; Gates VL; Benson Iii AB; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2016 Jun; 27(6):795-802. PubMed ID: 27038686 [TBL] [Abstract][Full Text] [Related]
3. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization. Liu Y; Cheng C; Zhou H; Hu S; Wang H; Xie Q; Lei L; Wang P; Liu G; Hu H Bull Cancer; 2021 Oct; 108(10):931-939. PubMed ID: 34247763 [TBL] [Abstract][Full Text] [Related]
5. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815 [TBL] [Abstract][Full Text] [Related]
6. Nomogram and Artificial Neural Network for Prognostic Performance on the Albumin-Bilirubin Grade for Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Zhong BY; Ni CF; Ji JS; Yin GW; Chen L; Zhu HD; Guo JH; He SC; Deng G; Zhang Q; Li PC; Yu H; Song JJ; Teng GJ J Vasc Interv Radiol; 2019 Mar; 30(3):330-338. PubMed ID: 30819473 [TBL] [Abstract][Full Text] [Related]
7. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408 [No Abstract] [Full Text] [Related]
8. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma. Young LB; Tabrizian P; Sung J; Biederman D; Bishay VL; Ranade M; Patel RS; Nowakowski FS; Fischman AM; Lookstein RA; Kim E J Vasc Interv Radiol; 2022 May; 33(5):510-517.e1. PubMed ID: 35150838 [TBL] [Abstract][Full Text] [Related]
9. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma. Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. Gui B; Weiner AA; Nosher J; Lu SE; Foltz GM; Hasan O; Kim SK; Gendel V; Mani NB; Carpizo DR; Saad NE; Kennedy TJ; Zuckerman DA; Olsen JR; Parikh PJ; Jabbour SK Am J Clin Oncol; 2018 Sep; 41(9):861-866. PubMed ID: 28418940 [TBL] [Abstract][Full Text] [Related]
11. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K; Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219 [TBL] [Abstract][Full Text] [Related]
13. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization. Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739 [TBL] [Abstract][Full Text] [Related]
14. ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma. Na SK; Yim SY; Suh SJ; Jung YK; Kim JH; Seo YS; Yim HJ; Yeon JE; Byun KS; Um SH J Surg Oncol; 2018 Apr; 117(5):912-921. PubMed ID: 29448306 [TBL] [Abstract][Full Text] [Related]
15. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study. Lee SK; Song MJ; Kim SH; Park M PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923 [TBL] [Abstract][Full Text] [Related]
16. A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function. Nam JY; Choe AR; Sinn DH; Lee JH; Kim HY; Yu SJ; Kim YJ; Yoon JH; Lee JM; Chung JW; Choi SY; Lee JK; Baek SY; Lee HA; Kim TH; Yoo K BMC Cancer; 2020 Jun; 20(1):504. PubMed ID: 32487089 [TBL] [Abstract][Full Text] [Related]
17. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. Pinato DJ; Sharma R; Allara E; Yen C; Arizumi T; Kubota K; Bettinger D; Jang JW; Smirne C; Kim YW; Kudo M; Howell J; Ramaswami R; Burlone ME; Guerra V; Thimme R; Ishizuka M; Stebbing J; Pirisi M; Carr BI J Hepatol; 2017 Feb; 66(2):338-346. PubMed ID: 27677714 [TBL] [Abstract][Full Text] [Related]
18. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT). Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502 [TBL] [Abstract][Full Text] [Related]